Sintomas respiratórios no cancro avançado

Autores

  • Ferraz Gonçalves Assistente graduado de Medicina Interna, Unidade de Cuidados Continuados do Instituto Português de Oncologia do Porto
  • Carolina Monteiro Assistente de Medicina Interna, Unidade de Cuidados Continuados do Instituto Português de Oncologia do Porto

Palavras-chave:

tratamento paliativo, cancro avançado, sintomas respiratórios, dispneia, tosse, hemoptise

Resumo

O envolvimento pulmonar no cancro é um sinal
de mau prognóstico. A frequência dos sintomas
respiratórios aumenta com a evolução do cancro.
Tornam-se, muitas vezes, nos sintomas mais
importantes e nos que mais significativamente
afectam a qualidade de vida. O seu controlo é, não
raras vezes, difícil. Revêem-se as causas, diagnóstico
e tratamento da dispneia, da tosse e das hemoptises no cancro avançado.

Downloads

Não há dados estatísticos.

Referências

Ahmedzai S. Palliation of respiratory symptoms. In Doyle D, Hanks GWC, MacDonald N, eds. Oxford textbook of palliative medicine.

Oxford: Oxford University Press, 2ª ed, 1998:584-616.

Escalante CP, Martin CG, Elting LS, et al. Dyspnea in cancer patients: etiology, resource utilization, and survival - implications

in a managed care world. Cancer 1996;78:1314-1319.

Higginson I, MacCarthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J Royal Soc Med

;82:264-267.

Dudgeon DJ, Rosenthal S. Management of dyspnea and cough in patients with cancer. Hematol/Onc Clin North Am 1996;10:157-

Ripamonti C, Bruera E. Dyspnea: pathophysiology and assessment. J Pain Symptom Manage 1997;13:220-232.

Appendix B: Definitions and ratings for individual’s symptoms which can be added to STAS. In Higginson I,ed. Clinical audit in

palliative care. Oxford: Radcliffe Medical Press 1993:182-186.

Helms SR, Carlson MD. Cardiovascular emergencies. Semin Oncol 1989;16:463-470.

Cowcher K, Hanks GW. Long-term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage

;5:320-330.

Spain RC, Whittlesey D. Respiratory emergencies in patients with cancer. Semin Oncol 1989;16:471-489.

Light RW. Pleural diseases. DM 1992;38:292-298.

Press OW, Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987;257:1088-1092.

Miller AC, Harvey JE. Guidelines for the management of spontaneous pneumothorax. BMJ 1993;307:114-116.

Bone RC. Ventilation/perfusion scan in pulmonary embolism: ‘the emperor is incompletely attired’. JAMA 1990;263:2794-2795.

Levine M, Hirsh J. The diagnosis and treatment of thrombosis in the cancer patient. Semin Oncol 1990; 17:160-171.

Carlson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-1245.

Thromboembolic Risk Factors Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients.

BMJ 1992;305:567-574.

Goldhaber SZ, Morpurgo M. Diagnosis, treatment, and prevention of pulmonary embolism: report of the WHO/International Society

and Federation of Cardiology Task Force. JAMA 1992; 268:1727-1733.

The PIOPED investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-2759.

Johnson MJ. Problems of coagulation within a palliative care setting: na audit of hospice patients taking warfarin. Palliat Med

; 11:306-312.

MJ Johnson, Sherry K. How do palliative physicians manage venous thromboembolism? Palliat Med 1997; 11:462-468.

Quelch PC, Faulkner DE, Yun JWS. Nebulized opioids in the treatment of dyspnea. J Palliat Care 1997;13:48-52.

Johnson MA, Woodcock, Geddes DM. Dihydrocodeine for breathlessness in “pink puffers”. BMJ 1983;286:675-677.

Robin ED, Burke CM. Single-patient randomized clinical trial opiates for intratable dyspnea. Chest 1986;90:888-892.

Bruera E, Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer

patients: Lancet 1993; 342:13-14.

Booth S, Kelly M, Adams L, Cox N. The treatment of dyspnoea in hospice patients - does oxygen help? Palliat Med 1994; 8:71-

Wilcock A, Corcoran R, Tattersfield AE. Safety and efficacy of nebulized lignocaine in patients with cancer and breathlessness.

Palliat Med 1994; 8:35-38.

Twycross R. Respiratory symptoms. In Twycross R ed. Symptom Management in Advanced Cancer. Oxon: Radcliffe Medical Press

: 143-157.

Hagen NA. An approach to cough in cancer patients. J Pain Symptom Manage 1991; 6:257-262.

Lipchik RJ. Hemoptysis. in Berger AM, Portenoy RK, Weissman DE eds. Principles and practice of supportive oncology.

Philadelphia: Lippincott-Raven Publishers 1998:309-314.

Twycross R. Haematological symptoms. In Twycross R ed. Symptom Management in Advanced Cancer. Oxon: Radcliffe

Medical Press 1997: 222-245.

Gonçalves F. Os últimos dias de vida. Arquivos Medicina 1997; 11:229-23

Ficheiros Adicionais

Publicado

29-12-2000

Como Citar

1.
Gonçalves F, Monteiro C. Sintomas respiratórios no cancro avançado. RPMI [Internet]. 29 de Dezembro de 2000 [citado 27 de Maio de 2024];7(4):225-33. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/2012

Edição

Secção

Artigos de Revisão